Logo image of CAN

CANAAN INC (CAN) Stock Fundamental Analysis

NASDAQ:CAN - Nasdaq - US1347481020 - ADR - Currency: USD

0.6323  -0.03 (-4.01%)

Premarket: 0.6359 +0 (+0.57%)

Fundamental Rating

3

Overall CAN gets a fundamental rating of 3 out of 10. We evaluated CAN against 32 industry peers in the Technology Hardware, Storage & Peripherals industry. CAN may be in some trouble as it scores bad on both profitability and health. CAN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CAN has reported negative net income.
In the past year CAN has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: CAN reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CAN reported negative operating cash flow in multiple years.
CAN Yearly Net Income VS EBIT VS OCF VS FCFCAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

The Return On Assets of CAN (-54.00%) is worse than 81.25% of its industry peers.
CAN has a Return On Equity (-93.98%) which is in line with its industry peers.
Industry RankSector Rank
ROA -54%
ROE -93.98%
ROIC N/A
ROA(3y)-42.47%
ROA(5y)-22.42%
ROE(3y)-67.02%
ROE(5y)-38.23%
ROIC(3y)N/A
ROIC(5y)N/A
CAN Yearly ROA, ROE, ROICCAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CAN Yearly Profit, Operating, Gross MarginsCAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

CAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CAN has been increased compared to 1 year ago.
Compared to 5 years ago, CAN has more shares outstanding
The debt/assets ratio for CAN is higher compared to a year ago.
CAN Yearly Shares OutstandingCAN Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
CAN Yearly Total Debt VS Total AssetsCAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

CAN has an Altman-Z score of -1.04. This is a bad value and indicates that CAN is not financially healthy and even has some risk of bankruptcy.
CAN has a Altman-Z score of -1.04. This is in the lower half of the industry: CAN underperforms 75.00% of its industry peers.
CAN has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CAN (0.03) is better than 78.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -1.04
ROIC/WACCN/A
WACC8.85%
CAN Yearly LT Debt VS Equity VS FCFCAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

CAN has a Current Ratio of 1.87. This is a normal value and indicates that CAN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.87, CAN is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
A Quick Ratio of 1.34 indicates that CAN should not have too much problems paying its short term obligations.
CAN has a better Quick ratio (1.34) than 65.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.34
CAN Yearly Current Assets VS Current LiabilitesCAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for CAN have decreased strongly by -45.28% in the last year.
CAN shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.20%.
Measured over the past years, CAN shows a small growth in Revenue. The Revenue has been growing by 5.48% on average per year.
EPS 1Y (TTM)-45.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1018.75%
Revenue 1Y (TTM)27.2%
Revenue growth 3Y-29.66%
Revenue growth 5Y5.48%
Sales Q2Q%135.9%

3.2 Future

CAN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 80.78% yearly.
Based on estimates for the next years, CAN will show a very strong growth in Revenue. The Revenue will grow by 88.91% on average per year.
EPS Next Y157.71%
EPS Next 2Y80.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year168.39%
Revenue Next 2Y88.91%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CAN Yearly Revenue VS EstimatesCAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
CAN Yearly EPS VS EstimatesCAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.5 -0.5 -1 -1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

CAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 1.08, the valuation of CAN can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CAN indicates a rather cheap valuation: CAN is cheaper than 100.00% of the companies listed in the same industry.
CAN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 1.08
CAN Price Earnings VS Forward Price EarningsCAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAN Per share dataCAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CAN's earnings are expected to grow with 80.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y80.78%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CAN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANAAN INC

NASDAQ:CAN (5/29/2025, 8:00:01 PM)

Premarket: 0.6359 +0 (+0.57%)

0.6323

-0.03 (-4.01%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)05-20 2025-05-20/bmo
Earnings (Next)08-13 2025-08-13
Inst Owners31.25%
Inst Owner Change2.4%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap291.09M
Analysts82.22
Price Target3.93 (521.54%)
Short Float %81.53%
Short Ratio1.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-179.43%
Min EPS beat(2)-434.65%
Max EPS beat(2)75.8%
EPS beat(4)3
Avg EPS beat(4)-63.09%
Min EPS beat(4)-434.65%
Max EPS beat(4)75.8%
EPS beat(8)3
Avg EPS beat(8)-86.14%
EPS beat(12)5
Avg EPS beat(12)-52.69%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.19%
Min Revenue beat(2)0.05%
Max Revenue beat(2)2.33%
Revenue beat(4)4
Avg Revenue beat(4)13.6%
Min Revenue beat(4)0.05%
Max Revenue beat(4)37.08%
Revenue beat(8)6
Avg Revenue beat(8)9.03%
Revenue beat(12)8
Avg Revenue beat(12)49.49%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.94%
PT rev (3m)-13.24%
EPS NQ rev (1m)10.34%
EPS NQ rev (3m)-225%
EPS NY rev (1m)0%
EPS NY rev (3m)428%
Revenue NQ rev (1m)4.41%
Revenue NQ rev (3m)-9.89%
Revenue NY rev (1m)1.95%
Revenue NY rev (3m)35.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.08
P/S 1.08
P/FCF N/A
P/OCF N/A
P/B 1.09
P/tB 1.43
EV/EBITDA N/A
EPS(TTM)-2.09
EYN/A
EPS(NY)0.59
Fwd EY92.65%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS0.59
BVpS0.58
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -54%
ROE -93.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-42.47%
ROA(5y)-22.42%
ROE(3y)-67.02%
ROE(5y)-38.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 67.86%
Cap/Sales 7.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.87
Quick Ratio 1.34
Altman-Z -1.04
F-Score4
WACC8.85%
ROIC/WACCN/A
Cap/Depr(3y)38.45%
Cap/Depr(5y)94.83%
Cap/Sales(3y)3.6%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-45.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1018.75%
EPS Next Y157.71%
EPS Next 2Y80.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)27.2%
Revenue growth 3Y-29.66%
Revenue growth 5Y5.48%
Sales Q2Q%135.9%
Revenue Next Year168.39%
Revenue Next 2Y88.91%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year119.56%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.48%
OCF growth 3YN/A
OCF growth 5YN/A